Alfred Yellson

Doctor of Osteopathic Medicine,  The Johns Hopkins Hospital 

Location: United States

Consulting Services

Biostatistics Research Consulting Sales and Marketing Data Science-Bioinformatics

Areas Of Interest

Transporters, SLC12A Headache, Vertex C. capucinus Rh Factor Sneezing Neoplasm Idiopathic Extrahepatic Biliary Atresia Leishmania viannia Apo AI Deformities, Congenital Hand Esophageal Diverticula Tonic-Clonic Seizures Stromal Tumor, Gastrointestinal Leucotomies Weakness, Muscular Extracts, Crude Sensitizations, Central Vicasol Ravtansine Government Regulation Dysfunction, Neurologic Temperature, Organ Chronic Traumatic Encephalopathy Gram Negative Anaerobic Cocci End-Systolic Volume, Ventricular Procyclidine Nystagmus, Physiologic Parenthood Status Sulphanilamide Glossopyrosis Study, Nested Case-Control Polycystic Ovary Syndrome 1 Spleen Cancer PMSG (Gonadotropins)

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 2005
Assistant Professor, Harvard Med 1993

Education

Doctor of osteopathic medicine, Yale School of Medicine 2006
Master of Science in physician assistant, Perelman School of Medicine 2003

Referees

Publications

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02